Showing 6,721 - 6,740 results of 226,904 for search '(( a ((we decrease) OR (a decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 1.44s Refine Results
  1. 6721

    <i>Per2</i><sup><i>m/m</i></sup> mice show a decrease in retinal thickness. by Vaishnavi Jadhav (3134835)

    Published 2016
    “…(B) The measurements of retinal thickness were performed by placing the 2 calipers (C01 & C02) near the optic nerve; the bar chart shows a decrease in retinal thickness of <i>Per2</i><sup><i>m/m</i></sup>. n = 6, *p<0.05.…”
  2. 6722
  3. 6723
  4. 6724

    Brain region that showed a greater decrease of alpha band oscillatory brain activity under the stress compared with the control condition. by Chika Nakamura (8345844)

    Published 2020
    “…<p>Brain region that showed a greater decrease of alpha band oscillatory brain activity under the stress compared with the control condition.…”
  5. 6725
  6. 6726
  7. 6727
  8. 6728
  9. 6729
  10. 6730
  11. 6731
  12. 6732

    PPARγ agonists have a protective role in BSA-induced tubulointerstitial damage, decrease proteinuria and prevent downregulation of megalin. by Felipe Cabezas (231082)

    Published 2011
    “…In control animals, megalin protein is abundantly expressed in the apical pole of proximal tubule cells (PTCs), whereas the BSA-treated animals exhibited a decrease in megalin immunostaining of the apical pole of PTCs, especially in areas where tubular dilatation with intraluminal proteinaceous casts were evident (arrow). …”
  13. 6733

    rVλ6Wil fibrils cause a decrease in cardiomyocytes MTT reduction without inducing cell death. by Helen P. McWilliams-Koeppen (116503)

    Published 2015
    “…(C) Cell number, quantified using crystal violet (black) did not decrease over 72 h of incubation with 1 μM rVλ6Wil fibrils despite a decrease in MMT reduction (grey; n = 3 samples per time point). …”
  14. 6734
  15. 6735
  16. 6736

    <i>In vitro</i> and <i>in vivo</i> tumorigenesis of A172 and U373 cells treated with miR-326 precursor. by Jingxu Zhou (433624)

    Published 2013
    “…The tumors were measured in two dimensions using a caliper on different days. The volume (mm<sup>3</sup>) was calculated using the formula V = 0.5* larger diameter *(smaller diameter)<sup> 2</sup>. miR-326 overexpression or <i>NOB1</i> shRNA significantly inhibited tumor formation. …”
  17. 6737

    A double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: A pilot study by Toshiko Tanaka (174638)

    Published 2017
    “…To determine whether acute increase or decrease uric acid levels affects inflammation in healthy individuals, a randomized, placebo-controlled, double blind clinical study of uric acid or rasburicase with 20 healthy volunteers in each treatment-placebo group was conducted at the National Institute on Aging (NIA) Clinical Research Unit (CRU) at Harbor Hospital in Baltimore, MD. …”
  18. 6738
  19. 6739

    <i>In Vivo</i> Modelling of <i>ATP1A3</i> G316S-Induced Ataxia in <i>C</i>. <i>elegans</i> Using CRISPR/Cas9-Mediated Homologous Recombination Reveals Dominant Loss of Function Def... by Altar Sorkaç (3391754)

    Published 2016
    “…Using CRISPR/Cas9-mediated homologous recombination for genome editing, we modelled this putative disease-causing allele in <i>Caenorhabditis elegans</i>, recreating the patient amino acid change in <i>eat-6</i>, the orthologue of <i>ATP1A3</i>. …”
  20. 6740

    Table_2_The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.DOCX by Laila Abdullah (705077)

    Published 2020
    “…<p>We examined the effects of a dihydropyridine calcium channel blocker nilvadipine with anti-inflammatory properties on cognition and cerebrospinal fluid (CSF) biomarkers by baseline Alzheimer's disease (AD) severity. …”